those expressed in the forward-looking
statements, including, but not limited to, certain delays beyond bioMETRX's
control with respect to market acceptance of their technology and/or
products, whether financing will be available, the effect of the
application of acquisition accounting policies as well as certain other
risk factors which are and may be detailed from time to time in bioMETRX's
filings with the Securities and Exchange Commission.